Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Icatibant effective in acute hereditary angioedema attacks

Feb. 28, 2007

Novel 5-HT2C antagonist developed at BMS for the treatment of obesity

Feb. 28, 2007

Devgen awarded grant to support obesity program

Feb. 27, 2007

Kuros' solitary bone cyst product awarded U.S. orphan drug status

Feb. 27, 2007

Approvable letter for Galvus

Feb. 26, 2007

(-)-Epigallocatechin-3-gallate lipophilic analogue shows antidiabetic activity in vitro and in vivo

Feb. 26, 2007

Roche suspends recruitment in phase II CERA study

Feb. 26, 2007

Rosiglitazone linked to increased incidence of fractures in female patients

Feb. 26, 2007

CureDM reports diabetes preclinical milestones

Feb. 26, 2007

Development of AOD-9604 in obesity terminated following phase IIb results

Feb. 26, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...